Skip to main content
HL CORP (SHENZHEN) logo

HL CORP (SHENZHEN) — Investor Relations & Filings

Ticker · 002105 ISIN · CNE000001Q77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,593 across all filing types
Latest filing 2024-04-23 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 002105

About HL CORP (SHENZHEN)

https://www.hlcorp.com

HL CORP (SHENZHEN) specializes in the research, development, and manufacturing of bicycle components and fitness equipment. The company is widely recognized for its 'ZOOM' brand, producing a comprehensive range of products including handlebars, stems, seat posts, suspension forks, and braking systems. Its portfolio also encompasses specialized components for electric bicycles and rehabilitation equipment. Serving as a major supplier for the global cycling market, the firm provides original equipment manufacturer (OEM) and original design manufacturer (ODM) services to numerous international brands. HL CORP (SHENZHEN) focuses on technical innovation, precision engineering, and large-scale production capabilities to meet diverse performance and safety requirements. The company integrates advanced materials and ergonomic designs to enhance product durability and user experience across various cycling disciplines.

Recent filings

Filing Released Lang Actions
关于2023年年度报告网上说明会公开征集问题的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (734 characters) from Shenzhen Xinlong Health Industry Development Co., Ltd. It references the company's 2023 Annual Report already published on April 24, 2024, and announces an upcoming online performance explanation meeting (webinar) scheduled for May 17, 2024. The document invites investors to submit questions in advance for the meeting. There is no actual financial data or detailed report content included, only a notice about the event related to the annual report. According to the 'Menu vs Meal' rule, this is an announcement about a report-related event, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2024-04-23 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen Xinlong Health Industry Development Co., Ltd. regarding a change in accounting policies. It details the nature of the accounting policy changes, the reasons based on new accounting standards issued by the Ministry of Finance, the impact on financial statements, and the supervisory board's opinion. The document is relatively short (2599 characters) and does not contain full financial statements or comprehensive financial performance data. It is a regulatory announcement about accounting policy changes rather than a full annual or interim report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-23 Chinese
2023年独立董事述职报告-王巍望
Board/Management Information Classification · 95% confidence The document is a detailed annual report by an independent director of Shenzhen Xinlong Health Industry Development Co., Ltd. It covers the director's duties, opinions on various company matters including audit firm appointment, profit distribution, internal control, remuneration, accounting policy changes, and stock incentive plans for the year 2023. The content is comprehensive, includes financial and governance-related opinions, and is dated April 2024, referring to the 2023 fiscal year. It is not a brief announcement or a transcript but a substantive report on the director's annual duties and opinions, which aligns with the category of Board/Management Information (MANG). It is not an Annual Report (10-K) or Audit Report (AR) because it focuses on the independent director's report and opinions rather than full financial statements or audit results. Therefore, the best classification is MANG with high confidence.
2024-04-23 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the eighth meeting of the seventh Supervisory Board of Shenzhen Xinlong Health Industry Development Co., Ltd. It includes multiple agenda items such as the review and approval of the 2023 Supervisory Board Work Report, the 2023 Financial Final Accounts Report, the 2023 Profit Distribution Plan, the 2023 Internal Control Self-Evaluation Report, Supervisory Board remuneration, accounting policy changes, the 2023 Annual Report and its summary, bank credit line applications for 2024, and the 2024 daily related party transaction plan. The document contains substantive financial data (e.g., revenue, net profit, asset totals, profit distribution details) and management oversight information. It is not merely an announcement of a report publication but includes actual financial results and supervisory board decisions. The document is not a full Annual Report (10-K) but rather a Supervisory Board meeting resolution announcement with financial and operational oversight content. This type of document fits best under the category of Regulatory Filings (RNS) because it is a formal regulatory announcement of supervisory board meeting resolutions and related financial and governance matters, not a full annual report or standalone audit report. The document length (6024 characters) and content support this classification.
2024-04-23 Chinese
2023年独立董事述职报告-陈大路
Management Reports Classification · 95% confidence The document is a detailed annual report by an independent director of Shenzhen Xinlong Health Industry Development Co., Ltd. for the year 2023. It includes comprehensive information about the director's attendance at board and shareholder meetings, opinions on financial audits, profit distribution plans, internal control evaluations, remuneration, accounting policy changes, and various corporate governance matters. The document references the 2022 annual report and discusses the company's financial and operational status in detail. It is not a brief announcement or a presentation but a substantive report covering the director's duties and opinions over the fiscal year. This aligns with the category of Management Reports (MDA), which includes management's detailed explanation of financial results, business trends, and outlook. The document is too detailed and lengthy to be a simple announcement or regulatory filing, and it is not a full annual report (10-K) but rather a director's annual work report. Therefore, the best classification is MDA with high confidence.
2024-04-23 Chinese
2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2023 Annual Report Summary" of Shenzhen Xinlong Health Industry Development Co., Ltd. It contains detailed financial data for the year 2023, including main accounting data, quarterly financial data, shareholder information, and important matters related to the company. The content includes comprehensive financial performance, business overview, accounting policy changes, and shareholder structure, which are typical components of an Annual Report. The document length is 6653 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-23 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.